JIANGSU HANSOH PHARM FDA Approval ANDA 213363

ANDA 213363

JIANGSU HANSOH PHARM

FDA Drug Application

Application #213363

Application Sponsors

ANDA 213363JIANGSU HANSOH PHARM

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002

Application Products

001INJECTABLE;INTRAVENOUSEQ 50MG BASE/VIAL0MICAFUNGIN SODIUMMICAFUNGIN SODIUM
002INJECTABLE;INTRAVENOUSEQ 100MG BASE/VIAL0MICAFUNGIN SODIUMMICAFUNGIN SODIUM

FDA Submissions

UNKNOWN; ORIG1TA2020-12-09STANDARD

Submissions Property Types

ORIG1Null31

TE Codes

001PrescriptionAP
002PrescriptionAP

CDER Filings

JIANGSU HANSOH PHARM
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213363
            [companyName] => JIANGSU HANSOH PHARM
            [docInserts] => ["",""]
            [products] => [{"drugName":"MICAFUNGIN","activeIngredients":"MICAFUNGIN","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/09\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-12-09
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.